JPRN-UMIN000030354已完成未知
Evaluation of calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism: a real-world observational study - ETERNAL Study
Ono Pharmaceutical Co.,ltd.0 个研究点目标入组 3,000 人开始时间: 2017年12月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with history of hemodialysis for less than 3 months at the time of eligibility confirmation 2) Patients who are inpatients at the time of eligibility confirmation 3) Patients who are planned to undergo surgery or be admitted to hospital at the time of eligibility confirmation where this will affect evaluation 4) Patients determined to be unsuitable for registration by the lead principal investigator or subinvestigator
研究者
相似试验
招募中
不适用
Efficacy and safety of etelcalcetide in hemodialysis patients with secondary hyperparathyroidism inadequately controlled with cinacalcetJPRN-UMIN000030568Jinken Clinic20
已完成
不适用
Effect of calcium and citrate dialysate concentrations on the calcification propensity in hemodialysis; a prospective randomized controlled cross-over trial.Calcification propensity of serum of hemodialysis patients. Vascular calcification.100132961003843010003216NL-OMON44984Interne Geneeskunde, Nefrologie20
已完成
不适用
The calcification propensity of uremic patients on hemodialysis.Calcification propensity. Dialysis. Vascular Calcification.NL-OMON28230Maastricht University Medical CenterPO Box 58006202 AZ Maastricht, The Netherlands20
已完成
不适用
The effect of conversion of dialysate calcium concentration from 3.0 mEq/L to 2.5 mEq/L on mineral and bone disorder in chronic hemodialysis patientsChronic kidney disease-Mineral and Bone DisorderJPRN-UMIN000015153Fukuoka Dental College100
已完成
不适用
Investigation of the clinical effect of hemodialysis using electrolyzed waterrenal failure requiring hemodialysis (HD)JPRN-UMIN000025113ephrology, Osaka National Hospital, NHO40